Investment Management Associates Inc Gilead Sciences, Inc. Transaction History

Investment Management Associates Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$63.47 - $69.35 $1.15 Million - $1.26 Million	-18,131 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$60.0 - $68.46 $58,440 - $66,680	-974 Reduced 5.1%	18,131 $1.17 Million
Q4 2020 Mar 16, 2021	BUY	$56.65 - $64.55 $1.08 Million - $1.23 Million	19,105 New	19,105 $1.11 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Investment Management Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Investment Management Associates Inc with notifications on news.